|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12...20212223242526272829303132» |
- | New P1/2 trial: Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV (clinicaltrials.gov) - Apr 2, 2012
P1/2, N=138, Enrolling by invitation, Sponsor: Georgetown University
- Enrollment open: Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation (clinicaltrials.gov) - Mar 29, 2012
P2, N=90, Recruiting, Sponsor: University of Connecticut Health Center
Not yet recruiting --> Recruiting
- | Enrollment change: Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking (clinicaltrials.gov) - Mar 28, 2012
P3, N=257, Terminated, Sponsor: McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Not yet recruiting --> Recruiting N=116 --> 257
- Chantix (varenicline) / Pfizer
Trial completion: A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=100, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
N=116 --> 257 Recruiting --> Completed
- Enrollment closed: DARSSA: Dynamic Assessment and Referral System - Evaluation (clinicaltrials.gov) - Mar 27, 2012
P2, N=758, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Recruiting --> Active, not recruiting
- | fluoxetine / Generic mfg.
Enrollment closed: Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms (clinicaltrials.gov) - Mar 26, 2012
P3, N=206, Active, not recruiting, Sponsor: Butler Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change: p16 Methylation for Smoking Cessation (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=35, Completed, Sponsor: Duke University
Recruiting --> Active, not recruiting N=50 --> 35
- Trial completion: p16 Methylation for Smoking Cessation (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=35, Completed, Sponsor: Duke University
N=50 --> 35 Active, not recruiting --> Completed
- Enrollment change: Stop Smoking Therapy for Ontario Patients (clinicaltrials.gov) - Mar 22, 2012
P2, N=1767, Completed, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed N=3000 --> 1767
- ||||||| Chantix (varenicline) / Pfizer
Trial completion: ConNic3: Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype (clinicaltrials.gov) - Mar 22, 2012
P3, N=606, Completed, Sponsor: Duke University
N=3000 --> 1767 Recruiting --> Completed
- Trial completion: Stop Smoking Therapy for Ontario Patients (clinicaltrials.gov) - Mar 22, 2012
P2, N=1767, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Effectiveness of Pedialink CEASE Module (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=647, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed N=50 --> 647
- |||||||||| Chantix (varenicline) / Pfizer
New P2/3 trial: LiveForLife2: Tailored Smoking Cessation Treatment for LIVE FOR LIFE (clinicaltrials.gov) - Mar 20, 2012
P2/3, N=300, Active, not recruiting, Sponsor: Duke University
- Trial completion: Effectiveness of Pedialink CEASE Module (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=647, Completed, Sponsor: Massachusetts General Hospital
N=50 --> 647 Recruiting --> Completed
- Trial completion: Smoking Cessation in Alcoholics (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=103, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: Natural History of Attempts to Stop Smoking (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=238, Completed, Sponsor: University of Vermont
Recruiting --> Completed N=300 --> 238
- Trial completion: Natural History of Attempts to Stop Smoking (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=238, Completed, Sponsor: University of Vermont
N=300 --> 238 Active, not recruiting --> Completed
- Biomarker, Trial completion: Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults (clinicaltrials.gov) - Mar 12, 2012
P=N/A, N=122, Completed, Sponsor: Masonic Cancer Center, University of Minnesota
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Research to Improve Smoke Alarm Functioning and Maintenance (clinicaltrials.gov) - Mar 12, 2012
P=N/A, N=4500, Completed, Sponsor: Centers for Disease Control and Prevention
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures (clinicaltrials.gov) - Mar 7, 2012
P=N/A, N=2185, Enrolling by invitation, Sponsor: University of Pennsylvania
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- galantamine extended release / Generic mfg.
New P2 trial: Effect of Galantamine on Smoking Abstinence (clinicaltrials.gov) - Mar 6, 2012
P2, N=16, Active, not recruiting, Sponsor: University of Pennsylvania
- bupropion / Generic mfg.
Trial completion: Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke (clinicaltrials.gov) - Mar 6, 2012
P=N/A, N=0, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed
- Enrollment open, Biopsy: A Study to Obtain Normal Values of Inflammatory Variables From Healthy Subjects (clinicaltrials.gov) - Mar 5, 2012
P=N/A, N=120, Recruiting, Sponsor: University Medical Centre Groningen
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Mar 4, 2012
P4, N=500, Recruiting, Sponsor: Butler Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=100, Active, not recruiting, Sponsor: Ohio State University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment change: Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers (clinicaltrials.gov) - Mar 2, 2012
P=N/A, N=80, Recruiting, Sponsor: University of Surrey
Recruiting --> Active, not recruiting N=60 --> 80
- New P1/2 trial: Effects of Curcumin on Vascular Reactivity (clinicaltrials.gov) - Mar 1, 2012
P1/2, N=18, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- ||| Trial completion: Tobacco Quit Line Re-enrollments for the Underserved (clinicaltrials.gov) - Feb 29, 2012
P=N/A, N=2985, Completed, Sponsor: Alere Wellbeing
N=60 --> 80 Active, not recruiting --> Completed
- Clinical: Optimal TTM Tailoring for Population Cessation (clinicaltrials.gov) - Feb 27, 2012
P=N/A, N=3006, Active, not recruiting, Sponsor: University of Rhode Island
- Trial completion: To Examine Smoking Behavior of Prisoners - 1 (clinicaltrials.gov) - Feb 26, 2012
P=N/A, N=360, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | New P4 trial: Neuropsychological Prognosis Factors of Smoking Cessation (clinicaltrials.gov) - Feb 23, 2012
P4, N=135, Active, not recruiting, Sponsor: University Hospital, Montpellier
- Enrollment open: Integrated Treatment for Smoking Cessation & Anxiety in People With HIV (clinicaltrials.gov) - Feb 23, 2012
P1, N=12, Recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- | Chantix (varenicline) / Pfizer
New P4 trial, Monotherapy: COMBIVAR: Clinical Trial to Evaluate the Efficacy of Smoking Cessation (clinicaltrials.gov) - Feb 22, 2012
P4, N=322, Completed, Sponsor: Josep Maria Ramon Torrell, PhD
- | New P1 trial: Nicotine Lozenge Bioequivalence Study (clinicaltrials.gov) - Feb 20, 2012
P1, N=50, Completed, Sponsor: GlaxoSmithKline
- Trial completion: Investigation of Cycloserine as a Smoking Cessation Treatment (clinicaltrials.gov) - Feb 19, 2012
P1, N=34, Completed, Sponsor: Baylor College of Medicine
Not yet recruiting --> Recruiting Recruiting --> Completed
- | New P1/2 trial: Assessment of a New Surgical Smoke Clearing Technology in Laparoscopic Cholecystectomy (clinicaltrials.gov) - Feb 15, 2012
P1/2, N=30, Completed, Sponsor: Asalus Medical Instruments Limited
- | New P1/2 trial: PATH Partnering to Achieve Tobacco-free Health (clinicaltrials.gov) - Feb 14, 2012
P1/2, N=450, Active, not recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- || Chantix (varenicline) / Pfizer
New P2/3 trial: Smoking Habits and Smoking Cessation in Young Adults (clinicaltrials.gov) - Feb 8, 2012
P2/3, N=300, Recruiting, Sponsor: Tuula Toljamo
- Enrollment change: Interventions of Smoking Cessation During Pregnancy (clinicaltrials.gov) - Feb 5, 2012
P1, N=92, Completed, Sponsor: Hellenic Anticancer Society
Recruiting --> Completed N=130 --> 92
- Trial completion: Interventions of Smoking Cessation During Pregnancy (clinicaltrials.gov) - Feb 5, 2012
P1, N=92, Completed, Sponsor: Hellenic Anticancer Society
N=130 --> 92 Active, not recruiting --> Completed
- Enrollment closed, Metastases: Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (clinicaltrials.gov) - Feb 2, 2012
P1, N=10, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial initiation date: Computer-Based Program to Facilitate Readiness and Motivation for Smoking Cessation (clinicaltrials.gov) - Feb 1, 2012
P=N/A, N=150, Not yet recruiting, Sponsor: University of Oklahoma
Recruiting --> Active, not recruiting Initiation date: Apr 2011 --> Apr 2012
- Trial completion: HIPWOODS - Health Effects Related to Exposure to Particle Pollution From Woodburning Stoves (clinicaltrials.gov) - Jan 31, 2012
P=N/A, N=20, Completed, Sponsor: University of Aarhus
Initiation date: Apr 2011 --> Apr 2012 Enrolling by invitation --> Completed
- Enrollment change: SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation (clinicaltrials.gov) - Jan 30, 2012
P1, N=151, Completed, Sponsor: Center for Innovative Public Health Research
Enrolling by invitation --> Completed N=75 --> 151
- | New P2 trial: Tobacco Dependence Treatment Education for Dental Students (clinicaltrials.gov) - Jan 30, 2012
P2, N=94, Completed, Sponsor: University of Louisville
- Trial completion: SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation (clinicaltrials.gov) - Jan 30, 2012
P1, N=151, Completed, Sponsor: Center for Innovative Public Health Research
N=75 --> 151 Recruiting --> Completed
- || New P3 trial: Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis (clinicaltrials.gov) - Jan 23, 2012
P3, N=400, Recruiting, Sponsor: All India Institute of Medical Sciences, New Delhi
- New P1 trial: The Impact of Intravenous Bendavia (clinicaltrials.gov) - Jan 22, 2012
P1, N=6, Completed, Sponsor: Stealth Peptides, Inc.
- Trial initiation date: iQS: A Randomized Trial of Internet Access to Nicotine Patches (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=2475, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Completed Initiation date: Oct 2009 --> Mar 2011
- ||| Hetlioz (tasimelteon) / Vanda
Trial completion: Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects (clinicaltrials.gov) - Jan 18, 2012
P1, N=60, Completed, Sponsor: Vanda Pharmaceuticals
Initiation date: Oct 2009 --> Mar 2011 Recruiting --> Completed